Key result
Sutureless marsupialization shows ~85% five-year patency for post-ablation pulmonary vein stenosis.
Why the study?
Pulmonary vein stenosis is a rare but serious complication following catheter ablation for atrial fibrillation, motivating evaluation of mid-term outcomes of the sutureless marsupialization technique.
Does the sutureless marsupialization technique improve mid-term pulmonary vein patency in patients with acquired pulmonary vein stenosis or occlusion after catheter ablation?
Observational (n=6)
No
Does the sutureless marsupialization technique improve mid-term pulmonary vein patency in patients with acquired pulmonary vein stenosis or occlusion after catheter ablation?
The sutureless marsupialization technique provides a feasible surgical option with an 84.6% 5-year patency rate for patients with severe pulmonary vein stenosis or occlusion following catheter ablation.
May support sutureless marsupialization in selected post-ablation pulmonary vein stenosis cases; leaves open need for prospective validation before broader use.
OBJECTIVE: Pulmonary vein stenosis is a rare but serious complication following catheter ablation for atrial fibrillation. This study aimed to evaluate the mid-term outcomes of the sutureless marsupialization technique for acquired pulmonary vein stenosis or pulmonary vein occlusion. METHODS: Between 2006 and 2024, six patients (mean age: 54.5 ± 9.0 years) with severe pulmonary vein stenosis or pulmonary vein occlusion after catheter ablation underwent surgical repair using the sutureless marsupialization technique. This approach avoids direct suturing to the pulmonary vein wall by covering the opened vein with autologous or xenogeneic tissue (left atrial appendage, pericardium, or atrial wall). A total of 13 pulmonary veins were reconstructed. Restenosis was evaluated using follow-up computed tomography, and 5-year patency was estimated by Kaplan-Meier analysis. RESULTS: All patients underwent successful repair without perioperative complications. Covering materials included the left atrial appendage (n = 3), bovine pericardium (n = 2), autologous pericardium (n = 1), and atrial wall flap (n = 1). During a mean follow-up of 62.5 ± 46.5 months, restenosis occurred in 2 of 13 veins (15.4%) four months after surgery, both initially classified as stenotic lesions. All patients remained asymptomatic and required no further intervention. The 5-year patency rate was 84.6%. CONCLUSIONS: The sutureless marsupialization technique offers good mid-term outcomes for acquired pulmonary vein stenosis and pulmonary vein occlusion after catheter ablation. By avoiding direct vein wall suturing, this approach may reduce restenosis. These results support its potential as a surgical option in selected patients with this rare complication.
No takes yet. Share an insight, caveat, or question.
Shibahara et al. (2026) conducted an observational in Acquired pulmonary vein stenosis or occlusion after catheter ablation (n=6). Sutureless marsupialization technique was evaluated on 5-year patency rate of reconstructed pulmonary veins. The sutureless marsupialization technique for acquired pulmonary vein stenosis and occlusion after catheter ablation achieved an 84.6% 5-year patency rate, with restenosis occurring in 2 of 13 reconstructed veins.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: